drugset / Trial / NCT01481597
Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
Deuteporfin, a novel photodynamic drug developed in China, displays good photodynamic antitumor activity. The purpose of the present study is to investigate the safety and pharmacokinetics of intravenous deuteporfin in healthy Chinese volunteers following single-dose administration.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Deuteporfin | Unknown | 1 mg/kg | Intravenous |
| Comparator | Deuteporfin | Unknown | 2.5 mg/kg | Intravenous |
| Comparator | Deuteporfin | Unknown | 5 mg/kg | Intravenous |
| Comparator | Deuteporfin | Unknown | 7.5 mg/kg | Intravenous |
Indications
No indication recorded.